FDA APPROVES LABEL CHANGES FOR POTIGA AND VISION LOSS
Ohio Pharmaceutical Lawyer: Potiga Vision Loss
“On October 31, 2013, the FDA issued a drug safety communication informing the public that the Agency has approved changes to the drug label of the anti-seizure drug Potiga (active ingredient ezogabine),...